 George was a pioneer in genome sequencing and still is in genome sequencing and you've seen that drop in price and speed. So we are now doing things much faster and much more cost effectively. You've co-founded several companies in the space, Veritas Genetics, Nebula, Genomics. So teach us about what's happening because you're specifically making a big push to the idea of open access mechanisms because there's a lot of silos of data and we want to be able to leverage open access to data in safe ways that make it easier for medical research. Yeah, exactly. So there were two components from the very beginning for me. One was the technical part of bringing down the cost and we've pursued most recently fluorescent next gen sequencing and nanopores to help do that. We brought down 10 million fold in cost. But in addition to that technical part, there's a social component which is convincing people it's safe and that it's effective, that it does something that they care about. And the problem is it's kind of a seat belt situation where even after the seat belts were installed in your cars effectively free and even there were laws and so forth, to really get people to pay attention, you had to have a circuit that since your seat belt was sealed and then it would shut off the annoying sound. And I think we have a similar thing here where about 1% of the people are at risk for genetic diseases and they sort of feel like, well, I'm exempt because there's nobody in my family yet. But the thing is, that's almost always the scenario is there's nobody in your family until there is one. So what Veritas and Nebula do is Veritas brought the price down to $1,000 and started getting it out to closer to regular people, but Nebula brings it down to $0 and starts making the connection to researchers like pharmaceutical companies much more friction-free simultaneously making convincing arguments that there are two things that worry people. One is, is there data secure and Nebula can use in combination of blockchain and encryption, we can guarantee that the data is only used the way you originally wanted it to be used. You can secure it so that your physician can't see it, insurance companies can't see it, can't be subpoenaed because you never had it, nobody else has it. It can only be used for a list of things that you approved in advance that could benefit you and nothing that could be held against you and you don't need, you can even protect it from yourself so you don't learn anything that you don't want to learn. So that's a breakthrough and then the breakthrough of getting the drug companies to pay for your genome and maybe pay possibly paying you for the education and time completely blows away the $1,000 genome with making something where you could potentially profit from your genome without ever actually selling it to anyone.